Back to Peptide Database
ImmuneInvestigational

Tuftsin

Overview

Tuftsin is a naturally occurring tetrapeptide (Thr-Lys-Pro-Arg) cleaved from the Fc portion of the heavy chain of immunoglobulin G. It binds to specific receptors on phagocytes, enhancing chemotaxis, phagocytosis, and microbicidal activity. The therapeutic rationale is to augment innate immune responses in immunocompromised states or chronic infections.

Key Research Findings

Clinical studies in the 1980s and 1990s evaluated tuftsin and synthetic analogs in cancer, infections, and immune deficiency with modest benefit observed in small cohorts. No large-scale pivotal trials or regulatory approvals have been achieved, and the peptide remains investigational.

Route of Administration

Subcutaneous injection, Intravenous

Regulatory Status

Investigational

Interested in Tuftsin?

Find a verified provider experienced with Tuftsin protocols in your area. All providers are credentialed and use compliant sourcing.

Find a Tuftsin Provider

Related Peptides

Thymalin

Investigational

A peptide bioregulator originally extracted from bovine thymus gland, consisting of a mixture of polypeptides that modulate immune function. Thymalin restores T-cell mediated immunity by promoting T-lymphocyte maturation and differentiation in the thymus. It also normalizes the ratio of T-helper to T-suppressor cells and enhances phagocytic activity of neutrophils and macrophages.

LL-37

Research Phase

The only human cathelicidin antimicrobial peptide, a 37-amino acid cationic peptide cleaved from the precursor protein hCAP18. LL-37 disrupts microbial membranes through electrostatic interactions and exerts broad-spectrum activity against bacteria, fungi, and enveloped viruses. Beyond direct antimicrobial effects, it modulates innate immunity by recruiting immune cells, promoting angiogenesis, and regulating inflammatory cytokine release.

VIP (Vasoactive Intestinal Peptide)

Investigational

A 28-amino acid neuropeptide widely distributed in the central and peripheral nervous systems and immune cells. VIP acts through VPAC1 and VPAC2 receptors to produce potent anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines (TNF-alpha, IL-6, IL-12) and promoting regulatory T-cell differentiation. It also functions as a vasodilator, bronchodilator, and neuromodulator.

Thymosin Alpha 1 (Zadaxin)

Investigational

A 28-amino acid peptide originally isolated from thymic tissue (thymosin fraction 5) that serves as a potent immunomodulator. Thymosin alpha 1 enhances T-cell maturation, dendritic cell function, and antibody responses by activating Toll-like receptors (TLR2, TLR9) on innate immune cells. It promotes Th1 immune responses and augments vaccine efficacy while modulating inflammatory cytokine production.